MCM10 and esophageal squamous cell carcinoma: Furthermore, we aimed to evaluate whether previously reported MCM10 inhibitors Suramin and its analogues (NF157, NF546, and PPADS)29, 30 could inhibit ESCC cells growth and metastasis.